Hostname: page-component-5db58dd55d-m58mf Total loading time: 0 Render date: 2026-07-07T23:36:34.533Z Has data issue: false hasContentIssue false
  • English
  • Français

The effect of dietary n-3 fatty acids on serum concentrations of C-reactive protein: a dose–response study

Published online by Cambridge University Press:  01 August 2008

Trine Madsen ,
Jeppe H. Christensen ,
Mogens Blom  and
Erik B. Schmidt
Trine Madsen*
Affiliation:
Department of Cardiology, Aalborg Hospital, Denmark
Jeppe H. Christensen
Affiliation:
Department of Nephrology, Aalborg Hospital, Denmark
Mogens Blom
Affiliation:
Department of Clinical Biochemistry, Hjørring/Brønderslev Hospital, Denmark
Erik B. Schmidt
Affiliation:
Department of Cardiology, Aalborg Hospital, Denmark
*
*Corresponding Author: Dr Trine Madsen, fax +45 99322361, email tmadsen@dadlnet.dk
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

C-reactive protein (CRP) is a sensitive marker for low-grade inflammation. Long-chain n-3 polyunsaturated fatty acids (PUFA) have anti-inflammatory effects. The objective of the present study was to investigate the effect on serum levels of CRP of n-3 PUFA at two different doses. We also investigated correlations between CRP and the cellular contents of PUFA. Sixty healthy volunteers (twenty-five women and thirty-five men) were randomly assigned to three treatment groups in a double-blind design. The subjects received a supplement of either 6·6 g n-3 PUFA/d, 2·0 g n-3 PUFA/d or placebo (olive oil) for 12 weeks. CRP was measured using a highly sensitive assay. The median serum CRP concentration was 0·78 mg/l. No significant correlations were found between CRP and the content of n-3 PUFA in granulocytes or platelets. Subjects receiving n-3 PUFA had a significant (P<0·01) increase in the cellular contents of 20: 5n-3, 22: 5n-3 and 22: 6n-3, with the largest increase occurring in the group receiving 6·6 g PUFA/d. A significant (P<0·01) decrease in cellular content of 18: 2n-6 and 20: 4n-6 was observed simultaneously. Serum CRP concentrations, however, were unaffected by the PUFA-containing supplements. The present study shows that dietary supplementation with PUFA-containing supplements has no effect on serum concentrations of CRP, measured with a highly sensitive assay, in healthy subjects.

Keywords

Fatty acidsFish oilInflammationC-reactive protein

Information

Type
Research Article
Information
British Journal of Nutrition , Volume 89 , Issue 4 , April 2003 , pp. 517 - 522
Copyright
Copyright © The Nutrition Society 2003

References

Belluzzi, A, Boschi, S, Brignola, C, Munarini, A, Cariani, G & Miglio, F (2000) Polyunsaturated fatty acids and inflammatory bowel disease. American Journal of Clinical Nutrition 71, 339S–342S.CrossRefGoogle ScholarPubMed
Biasucci, LM, Liuzzo, G, Grillo, RL, Caligiuri, G, Rebuzzi, AG, Buffon, A, Summaria, F, Ginnetti, F, Fadda, G & Maseri, A (1999) Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99, 855–860.CrossRefGoogle ScholarPubMed
Brown, AJ, Pang, E & Roberts, DC (1991) Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications. American Journal of Clinical Nutrition 54, 668–673.CrossRefGoogle ScholarPubMed
Calder, PC (2001) Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36, 1007–1024.CrossRefGoogle ScholarPubMed
Campos, SP & Baumann, H (1992) Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. Molecular and Cellular Biology 12, 1789–1797.Google ScholarPubMed
Castell, JV, Gomez-Lechon, MJ, David, M, Fabra, R, Trullenque, R & Heinrich, PC (1990) Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12, 1179–1186.CrossRefGoogle ScholarPubMed
Caughey, GE, Mantzioris, E, Gibson, RA, Cleland, LG & James, MJ (1996) The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. American Journal of Clinical Nutrition 63, 116–122.CrossRefGoogle ScholarPubMed
Chan, DC, Watts, GF, Barrett, PH, Beilin, LJ & Mori, TA (2002) Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. Clinical Chemistry 48, 877–883.CrossRefGoogle ScholarPubMed
Christensen, JH, Christensen, MS, Dyerberg, J & Schmidt, EB (1999) Heart rate variability and fatty acid content of blood cell membranes: a dose–response study with n-3 fatty acids. American Journal of Clinical Nutrition 70, 331–337.CrossRefGoogle ScholarPubMed
De Caterina, R, Liao, JK & Libby, P (2000) Fatty acid modulation of endothelial activation. American Journal of Clinical Nutrition 71, 213S–223S.CrossRefGoogle ScholarPubMed
Erlandsen, EJ & Randers, E (2000) Reference interval for serum C-reactive protein in healthy blood donors using the Da de Behring N Latex CRP mono assay. Scandinavian Journal of Clinical Laboratory Investigation 60, 37–43.CrossRefGoogle Scholar
Ernst, E, Saradeth, T & Achhammer, G (1991) n-3 Fatty acids and acute-phase proteins. European Journal of Clinical Investigation 21, 77–82.CrossRefGoogle ScholarPubMed
James, MJ & Cleland, LG (1997) Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Seminars in Arthritis and Rheumatism 27, 85–97.CrossRefGoogle ScholarPubMed
James, MJ, Gibson, RA & Cleland, LG (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. American Journal of Clinical Nutrition 71, 343S–348S.CrossRefGoogle ScholarPubMed
Koenig, W, Sund, M, Frohlich, M, Fischer, HG, Lowel, H, Doring, A, Hutchinson, WL & Pepys, MB (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99, 237–242.CrossRefGoogle Scholar
Lee, TH & Austen, KF (1986) Arachidonic acid metabolism by the 5-lipoxygenase pathway, and the effects of alternative dietary fatty acids. Advances in Immunology 39, 145–175.CrossRefGoogle ScholarPubMed
Macy, EM, Hayes, TE & Tracy, RP (1997) Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clinical Chemistry 43, 52–58.CrossRefGoogle ScholarPubMed
Madsen, T, Skou, HA, Hansen, VE, Fog, L, Christensen, JH, Toft, E & Schmidt, EB (2001) C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. American Journal of Cardiology 88, 1139–1142.CrossRefGoogle ScholarPubMed
Meier-Ewert, HK, Ridker, PM, Rifai, N, Price, N, Dinges, DF & Mullington, JM (2001) Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clinical Chemistry 47, 426–430.CrossRefGoogle ScholarPubMed
Nielsen, GL, Faarvang, KL, Thomsen, BS, Teglbjaerg, KL, Jensen, LT, Hansen, TM, Lervang, HH, Schmidt, EB, Dyerberg, J & Ernst, E (1992) The effects of dietary supplementation with n-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a randomized, double blind trial. European Journal of Clinical Investigation 22, 687–691.CrossRefGoogle ScholarPubMed
Ridker, PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103, 1813–1818.CrossRefGoogle ScholarPubMed
Ridker, PM, Cushman, M, Stampfer, MJ, Tracy, RP & Hennekens, CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. New England Journal of Medicine 336, 973–979.CrossRefGoogle ScholarPubMed
Rifai, N, Tracy, RP & Ridker, PM (1999) Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clinical Chemistry 45, 2136–2141.CrossRefGoogle ScholarPubMed
Ross, R (1999) Atherosclerosis–an inflammatory disease. New England Journal of Medicine 340, 115–126.CrossRefGoogle ScholarPubMed
Schmidt, EB (1997) n-3 Fatty acids and the risk of coronary heart disease. Danish Medical Bulletin 44, 1–22.Google ScholarPubMed
Schmid, EB & Dyerberg, J (1989) n-3 Fatty acids and leucocytes. Journal of Internal Medicine 225, 151S–158S.CrossRefGoogle Scholar
Schmidt, EB, Pedersen, JO, Varming, K, Ernst, E, Jersild, C, Grunnet, N & Dyerberg, J (1991) n-3 Fatty acids and leukocyte chemotaxis. Effects in hyperlipidemia and dose–response studies in healthy men. Arterio-sclerosis and Thrombosis 11, 429–435.CrossRefGoogle ScholarPubMed
Simopoulos, AP (1999) Essential fatty acids in health and chronic disease. American Journal of Clinical Nutrition 70, 560S–569S.CrossRefGoogle ScholarPubMed
Steel, DM & Whitehead, AS (1994) The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunology Today 15, 81–88.CrossRefGoogle ScholarPubMed
Tataru, MC, Heinrich, J, Junker, R, Schulte, H, von Eckardstein, A, Assmann, G & Koehler, E (2000) C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. European Heart Journal 21, 1000–1008.CrossRefGoogle ScholarPubMed
Toss, H, Lindahl, B, Siegbahn, A & Wallentin, L (1997) Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation 96, 4204–4210.CrossRefGoogle Scholar